Rodriguez J A, Armadans L, Ferrer E, Olmos A, Codina S, Bartolomé J, Borrellas J, Piera L
Hospital General Universitario Vall d'Hebron, Servicio de Nefrologia, Barcelona, Spain.
Nephrol Dial Transplant. 2000 Mar;15(3):402-8. doi: 10.1093/ndt/15.3.402.
Complications arising from vascular access (VA) are major causes of morbidity in patients on renal replacement therapy (RRT). They contribute to frustration of health care providers and to high medical cost. To prevent failures in the future it will be helpful to identify the factors that are related to VA malfunction.
In a retrospective analysis we analysed the types, duration and primary rate of patency of 1033 permanent vascular accesses in 544 consecutive patients established during a 13-year period in a tertiary care hospital. Patient characteristics, incidence, and risk factors related to VA failure were registered. In addition, VA outcomes in patients who started haemodialysis with a catheter and in whom initial VA failure occurred were analysed separately.
Forty-five per cent of patients required a central catheter at the start of HD, but 92% of them were being dialysed with an a-v fistula at the last observation. The total number of complications was 0.24 episodes per patient per year at risk and the rate of thrombosis 0.1. A total of 52% of patients were dialysed throughout the observation period with their initial a-v fistula; 9.3% had more than three episodes of VA failure. The radiocephalic a-v fistula was the VA with the best median duration, exceeding 7 years, but also the type that had the highest initial failure rate, i.e. 25% of patients and 13% of the events. The brachiocephalic a-v fistula was the second most frequent type of VA, with a median duration of function of 3.6 years, in contrast to the humerobasilic a-v fistula, which exceeded 5 years. Average patency of the different types of grafts did not exceed 1 year, with the exception of the autologous saphenous graft with a median duration of function of 1.4 years. Patients with glomerulonephritis had the best function rates for their VA, the median exceeding the duration of the study, whereas in half of the diabetic patients it was less than 1 year. The duration of patency of the VA was twice in patients below age 65 years and in elderly males compared to elderly females. Patients who started HD with a catheter, as well as those with initial VA failure, had a higher rate of VA failure in the subsequent course on RRT.
The radiocephalic and the humerobasilic a-v fistulae are the two types of VA with the longest duration of function, although a high rate of initial failure is seen with the radiocephalic a-v fistula. Age, female gender, presence of diabetic nephropathy, start of dialysis with a catheter, and failure to wait for initial maturation of the VA are risk factors, and account for the majority of VA failures during RRT.
血管通路(VA)相关并发症是接受肾脏替代治疗(RRT)患者发病的主要原因。它们给医护人员带来困扰,并导致高昂的医疗费用。为防止未来出现故障,识别与VA功能障碍相关的因素将有所帮助。
在一项回顾性分析中,我们分析了一家三级护理医院在13年期间为544例连续患者建立的1033个永久性血管通路的类型、持续时间和初次通畅率。记录了患者特征、与VA失败相关的发生率和危险因素。此外,还分别分析了开始血液透析时使用导管且初次VA失败的患者的VA结局。
45%的患者在开始血液透析时需要中心静脉导管,但在最后一次观察时,其中92%的患者使用动静脉内瘘进行透析。每位有风险的患者每年并发症总数为0.24次,血栓形成率为0.1。在整个观察期内,共有52%的患者使用其初次建立的动静脉内瘘进行透析;9.3%的患者发生了三次以上的VA失败。桡动脉-头静脉内瘘是功能中位持续时间最长的VA类型,超过7年,但也是初始失败率最高的类型,即25%的患者和13%的事件。肱动脉-头静脉内瘘是第二常见的VA类型,功能中位持续时间为3.6年,而肱动脉-贵要静脉内瘘超过5年。除自体大隐静脉移植物功能中位持续时间为1.4年外,不同类型移植物的平均通畅时间不超过1年。肾小球肾炎患者的VA功能率最佳,中位持续时间超过研究期,而一半糖尿病患者的VA功能持续时间不到1年。65岁以下患者和老年男性的VA通畅持续时间是老年女性的两倍。开始血液透析时使用导管的患者以及初次VA失败的患者在后续RRT过程中VA失败率更高。
桡动脉-头静脉内瘘和肱动脉-贵要静脉内瘘是功能持续时间最长的两种VA类型,尽管桡动脉-头静脉内瘘初始失败率较高。年龄、女性性别、糖尿病肾病的存在、开始透析时使用导管以及未等待VA初次成熟是危险因素,并且占RRT期间VA失败的大多数。